ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ERNA Eterna Therapeutics Inc

1.72
0.01 (0.58%)
最終更新日: 22:53:08
15分遅延
名称 銘柄コード 市場 種別
Eterna Therapeutics Inc ERNA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.01 0.58% 1.72 22:53:08
始値 安値 高値 終値 前日終値
1.80 1.72 1.80 1.71
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/2/2022:30GLOBEEterna Therapeutics Announces the Appointment of Peter..
2024/2/1707:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/2/1621:30EDGAR2Form 8-K - Current report
2024/1/3121:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/2506:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/1/2314:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/1/2006:16EDGAR2Form 8-K - Current report
2024/1/2000:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/1706:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/1/1306:49EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/1/0407:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0407:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0407:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0406:15GLOBEEterna Therapeutics Grants New President and CEO Sanjeev..
2023/12/2302:05EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/12/2106:20EDGAR2Form 8-K - Current report
2023/12/2106:15GLOBEEterna Therapeutics Names Sanjeev Luther as President and..
2023/12/2105:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/12/2100:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1911:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1508:56GLOBEEterna Therapeutics Announces $9.2 Million Convertible Debt..
2023/12/1506:30EDGAR2Form 8-K - Current report
2023/11/1706:16EDGAR2Form 8-K - Current report
2023/11/1407:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/11/1322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0121:34EDGAR2Form 8-K - Current report
2023/11/0121:30GLOBEEterna Therapeutics Appoints James Bristol, Ph.D.,..
2023/10/0605:30EDGAR2Form 8-K - Current report
2023/9/2705:30EDGAR2Form 8-K/A - Current report: [Amend]
2023/9/0819:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2023/9/0806:26EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/9/0621:00GLOBEEterna Therapeutics Announces Initiation of Development..
2023/9/0521:30GLOBEEterna Therapeutics Appoints Biopharma Industry Veteran..
2023/9/0206:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/9/0105:15EDGAR2Form 8-K - Current report
2023/8/2905:57EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/8/2608:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2320:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1505:59EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/8/1205:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1106:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1106:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1105:10EDGAR2Form 8-K - Current report
2023/8/0306:25EDGAR2Form 8-K - Current report
2023/7/2706:05EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/7/1905:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1905:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1821:05EDGAR2Form 8-K - Current report
2023/7/1821:00GLOBEEterna Therapeutics Announces Completion of $8.7 Million of..
2023/7/1819:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock